Showing posts with label Sight. Show all posts
Showing posts with label Sight. Show all posts

Sunday, April 10, 2011

New Approaches To Dementia And Sight Loss - Report Of First National Conference Released Today, UK

Translate Request has too much data
Parameter name: request

Main Category: Alzheimer's / Dementia
Also Included In: Eye Health / Blindness
Article Date: 16 Mar 2011 - 1:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
5 starsnot yet rated
Key messages for professionals, policy makers, commissioners and carers are highlighted in a report released today (1) of the First National Conference on Dementia and Sight Loss.

The report, by the Dementia and Sight Loss Interest Group (DaSLIG), a coalition of leading charities, (2) summarises the presentations and discussions delivered at the recent National Conference in London. Organised by DaSLIG and sponsored by ARUP, the conference brought together over 70 delegates - sight loss and dementia specialists as well as representatives from bodies including the Department of Health, NHS and Social Care Institute for Excellence.

"This conference was a milestone in the bid to improve the lives of people living with both dementia and sight loss," said Sarah Buchanan, Research and Development Manager, Thomas Pocklington Trust. "It was the first major debate on this issue and it delivered crucial information and practical solutions for improving care. The report should be essential reading for all those involved in the care and support of people with dementia."

Of the estimated 750,000 people in the UK living with dementia, at least 100,000 will also have serious sight loss yet, in 2010, a review of existing dementia policy, practice and literature, summarised for the conference by Dr. Declan McKeefry (3), (Bradford University School of Optometry and Vision Science), concluded that all three displayed a "fundamental lack of sensitivity to sight loss."

He highlighted three main types of sight loss associated with dementia. A specific eye condition might occur at the same time as dementia; some forms of dementia affect vision, including perception of colour, depth and detail; and, thirdly, normal ageing of the eyes plays an important role since most people with dementia are over the age of 75.

Despite this, his research showed that few people with dementia appear to have access to regular eye tests.

"Ocular health screening is important in people with dementia, yet there's a reticence to refer them," he said.

At the conference, Fazilet Hadi, Group Director Inclusive Society, RNIB, spelled out the realities of living with dementia and sight loss. The emotional impact on people's identity, confidence and self worth are underestimated and a lot of people are not getting the services they need.

"Having both dementia and sight loss is qualitatively different than having one or the other. But when dementia is the main condition sight loss can be forgotten," she said.

Dr. Graham Stokes, Director of Dementia Care for BUPA, had seen many cases of dementia related sight loss. He called it "not seeing with true knowledge". In a moving account he described a man whose dementia and sight loss led to terror at his own reflection. Too often carers were insensitive to this kind of fear and alarm. He classified this as "malign care" and urged carers to "move beyond quality of care to quality of life." He listed practical examples for improving care in care homes. For example: how to deliver "high intensity engagement" to people with dementia. Even 90 seconds of interaction can give long-lasting feelings of wellbeing:

"The positive feeling exists far longer than the memory of the interaction," he said. "Carers, you do have time to give people one-to-one attention."

The National Dementia Strategy was setting a pathway for change, said Professor Sube Banerjee, leading specialist in dementia and co-leader on development of the national strategy.

"At the moment we spend a lot of money - late - on things that aren't of good quality," he said.

He cited "waiting too long and not focussing on prevention" as major failings. Late diagnosis was resulting in "harm, crisis and cost," he said, with only 30% of people with dementia ever diagnosed. Now, early diagnosis and intervention "including the diagnosis of important co-morbidities such as sight loss" is a key aim of the National Dementia Strategy.

The huge cost of dementia care - £17 billion a year in the UK - would be a powerful driver of change:

"Doing dementia care well will cost less than doing it badly. Doing it well becomes the solution rather than the problem."

Andrew Chidgey, Head of Policy and Public Affairs at the Alzheimer's Society, said the scene was set for achieving change.

"There is a willingness of people to talk more freely about members of their family who have dementia. With this increased awareness and willingness to act there is an opportunity now to do far more on dementia linked to sight loss."

Other speakers highlighted in the report include:

Professor David Croisdale-Appleby OBE (Skills for Care) on how qualifications available from January 2011 will improve the knowledge, understanding and status of social care staff.

Penny Redwood (freelance trainer) on how to recognise concurrent sight loss and dementia.

Pam Turpin, (ARUP) giving a room-by-room account of making a home dementia and sight loss friendly.

Notes:

1. Dementia and Sight Loss Conference - Summary of Conference available here.

2. The Dementia and Sight Loss Interest Group (DaSLIG) of VISION 2020 UK is led by Alzheimer's Society, Macular Disease Society, ARUP, Royal National Institute of Blind People (RNIB) and Thomas Pocklington Trust. This special interest group leads work to raise awareness of concurrent dementia and sight loss.

3. Research papers available here.
The key papers presented by Professor Sube Banerjee and Dr. Declan McKeefry are:
"The experiences and needs of people with dementia and serious visual impairment: a qualitative study" by Vanessa Lawrence, Joanna Murray, Dr. Dominic ffytche and Professor Sube Banerjee, King's College London.
"The development of professional guidelines for the eye examination of people with dementia" D. McKeefry. University of Bradford Schools of Optometry and Vision Science. The findings of this study are included in Thomas Pocklington Trust Research Discussion Paper number 8 - "Improving the provision of vision and eye health care to people with dementia"

4. The research led by Professor Sube Banerjee at Kings College, London, and supported by Thomas Pocklington Trust, shows that in dementia a person's orientation, recognition, recall and judgement are all exacerbated by sight loss, making the impact of dementia worse. Sight loss can increase feelings of confusion, isolation and fear and this, in turn, may trigger aggression. At the same time, a person's ability to cope with sight loss is reduced by dementia. Responding to people's sight loss, suggests the research, could reduce both the distress of dementia and the likelihood of disruptive behaviour.

Source:
Thomas Pocklington Trust

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

posted by Jim on 26 Mar 2011 at 12:11 am

My wife Patricia was diagnosed with alzheimers in 2000 at the age of 57. Her eyes are perfect, but the brain cells for seeing have died. She had trouble seeing in 1998, and is now blind. It is advisable to be checked out for alz if one is having to use spectacles for the first time at 35 years and over. Alzheimers may be the cause.

| post followup | alert a moderator |


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Saturday, April 9, 2011

Glaucoma Week Designed To Raise Awareness Of "Sneak Thief Of Sight"

Error in deserializing body of reply message for operation 'Translate'. The maximum string content length quota (8192) has been exceeded while reading XML data. This quota may be increased by changing the MaxStringContentLength property on the XmlDictionaryReaderQuotas object used when creating the XML reader. Line 1, position 8805.

Main Category: Eye Health / Blindness
Article Date: 14 Mar 2011 - 2:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Often referred to as the sneak thief of sight because it slowly causes vision loss, physicians and researchers at the Eugene and Marilyn Glick Eye Institute are trying to learn if glaucoma could be related to blood flow in the eye. Their discoveries could change treatment options for one of the leading cause of blindness in the U.S.

Glaucoma develops when pressure builds in the eye and causes damage to the optic nerve, explains Louis Cantor, M.D., chairman of the Department of Ophthalmology at the Glick Eye Institute. "The optic nerve is the main cable carrying the messages from the eye to the brain. Damage to the optic nerve can cause blind spots to develop, and those spots often go unnoticed until they increase in size, impairing sight," he said. "The result is vision loss that cannot be recovered."

This week is World Glaucoma Week, dedicated to bringing awareness to the disease. The observance is to raise awareness of the disease, which can occur without symptoms in up to 50 percent of patients who have glaucoma. In the United States, more than 4 million people have glaucoma. African-Americans and Hispanics are more susceptible to the disease although it strikes all races. Risk factors for glaucoma include:

- Age
- Being African-American or Hispanic
- Having a family history of glaucoma
- Having elevated eye pressure
- Being farsighted or nearsighted
- Having previous eye injuries
- Having other health problems such as diabetes, low blood pressure or migraine headaches.

Working with Alon Harris, Ph.D., director of clinical research for the Glick Eye Institute, Dr. Cantor hopes their approach to understanding glaucoma will benefit patients in Indiana and around the world. "In Indiana alone, the number of patients with glaucoma could fill Lucas Oil Stadium," he says. "And there are thousands more who have the disease who don't know it, and they are most at risk for vision loss."

Their study, the Indianapolis Glaucoma Progression Study, is the largest of its kind in the United States. With 120 patients enrolled for three years, the clinical trial is in its second year, and is focused on vascular - or blood flow - causes or effects of the disease. Dr. Harris is principal investigator of the study.

"I hope they learn something that can be applied to problems in the short run," said patient Jim Palmer, an Indianapolis resident. "This study of blood flow might find out that it is just as significant as pressure, and that could be of benefit to all glaucoma patients."

Dr. Harris explains that eye pressure is the most common measurement in glaucoma. But he notes that some patients develop glaucoma and don't experience the high ocular pressure common in other patients, and some of those patients without high pressure lose sight to the disease. The research is important to determine if blood flow plays a part in the disease.

Maybe, he said, some patients don't receive enough blood flow to their eyes. This study will help determine if improper blood flow is a side effect of the disease or a cause of the disease.

"Unlocking the answer to that question could give us different treatment options for glaucoma," Dr. Harris said. "Understanding the role the vascular system plays in the disease would bring a new way of looking at glaucoma patients."

Dr. Harris is an international expert on the field of ocular blood flow and has designed and perfected many of the diagnostic tests performed on the study patients.

"I've learned a fair amount about this disease because of participating in the study," Palmer said. "And they check so many different things that it would be cost-prohibitive to have all of this done if I did not participate in the study."

Palmer, 67, has experienced glaucoma since about 1986. He learned he had the disease when he saw an ophthalmologist for a detached retina. He currently manages his glaucoma with drops he uses three times a day.

Study participant Carolyn Christman also is a long-time glaucoma patient. "I've learned the newest information from the doctors and the fellows and it's been helpful to me to have this information about my glaucoma," she said. The 70-year-old patient has had glaucoma since she was 42.

"This study, working on the relationship between blood pressure and blood vessels around the eye, is interesting to me," she said. "Participating is my way of helping other people."

The opportunity to participate in a study that could determine new treatments also appealed to Ronnie Adams. The retired 70-year-old African-American says glaucoma runs in his family - his father lost vision in one eye due to the disease and his sister, who also has glaucoma, convinced him to have his eyes examined.

"I'd say the study experience has been really good," Adams said. "I don't want to lose my eyesight and right now it looks as if the drops I use are helping. It's important to try to do something to improve the situation or not lose vision."

Cantor and Harris say the participation of their study patients is crucial to their success in formulating new discoveries about glaucoma.

"We rely on our patients to help us understand why this disease strikes when it does," Cantor said. "We're interested in learning if the blood flow theory is one we could explore further and we need our study patients to help us."

Glaucoma is not the only disease that causes vision loss - but vision loss from many conditions can be prevented with proper care. Most people begin to experience changes in their vision as they turn 40, Dr. Cantor said. By age 65, one in three Americans will experience some form of vision-impairing eye disease.

Source:
IU School of Medicine

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Wednesday, April 6, 2011

The Sight And Smell Of Food Causes Binge Eaters' Dopamine Levels To Spike

Error in deserializing body of reply message for operation 'Translate'. The maximum string content length quota (8192) has been exceeded while reading XML data. This quota may be increased by changing the MaxStringContentLength property on the XmlDictionaryReaderQuotas object used when creating the XML reader. Line 1, position 8774.

Main Category: Eating Disorders
Also Included In: Obesity / Weight Loss / Fitness;  Endocrinology
Article Date: 01 Mar 2011 - 3:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet rated4 and a half stars
A brain imaging study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory reveals a subtle difference between ordinary obese subjects and those who compulsively overeat, or binge: In binge eaters but not ordinary obese subjects, the mere sight or smell of favorite foods triggers a spike in dopamine - a brain chemical linked to reward and motivation. The findings - published online in the journal Obesity - suggest that this dopamine spike may play a role in triggering compulsive overeating.

"These results identify dopamine neurotransmission, which primes the brain to seek reward, as being of relevance to the neurobiology of binge eating disorder," said study lead author Gene-Jack Wang, a physician at Brookhaven Lab and the Mount Sinai School of Medicine. Previous studies conducted by Wang's team have identified a similar dopamine spike in drug-addicted individuals when they were shown images of people taking drugs, as well as other neurochemical similarities between drug addiction and obesity, including a role for dopamine in triggering desire for drugs and/or food.

"In earlier studies of normal-weight healthy people who had been food-deprived for 16 hours, we found that dopamine releases were significantly correlated with self-reports of hunger and desire for food. These results provided evidence of a conditioned-cue response to food," Wang said.

In the current study, the researchers suspected that binge-eating obese subjects would show stronger conditioned responses to food stimuli when compared with non-binging obese subjects.

"Understanding the neurobiological mechanisms underlying food stimulation might point us toward new ways to help individuals regulate their abnormal eating behaviors," Wang said.

The scientists studied 10 obese people with a clinical diagnosis of binge eating disorder, based on evaluations at St. Luke's-Roosevelt Hospital, and 8 obese subjects who were not binge eaters.

The scientists used positron emission tomography (PET) to scan the subjects' brains after injecting a radiotracer designed to bind to dopamine receptors in the brain. Because the tracer competes with the brain's natural dopamine to bind to these receptors, the signal picked up by the PET scanner provides an inverse measure of the brain's dopamine levels: a strong signal from the bound tracer indicates low levels of natural brain dopamine; a low signal from the tracer indicates high levels of dopamine in the brain.

Each subject was scanned four times on two different days to test the effects of food stimulation vs. neutral stimulation with and without pre-administration of a drug known to amplify dopamine signals. The drug, methylphenidate, blocks the reuptake of dopamine from brain synapses, allowing it to linger longer. In scans without methylphenidate, subjects were given a placebo drug.

In the food stimulation condition, research subjects' favorite foods were heated (if appropriate) and waved in front of their mouths and noses so they could smell and even taste tiny amounts swabbed onto their tongues. For the neutral stimulation scans, researchers displayed non-food-related pictures and inanimate objects such as toys and clothing items in close proximity so research subjects could smell them while lying in the scanner. In all cases, research subjects had been fasting for 16 hours prior to scans. Results

Food stimulation with methylphenidate significantly increased dopamine levels in the caudate and putamen regions of the brain in binge eaters but not in the non-binge eaters. Subjects with the most severe binge eating disorder, as assessed by psychological evaluations, had the highest dopamine levels in the caudate.

Dopamine levels did not rise significantly in other brain regions or under any other condition (neutral stimulation with or without methylphenidate, or food stimulation without methylphenidate) in either group, and were not correlated with body mass index of the research subjects. Assessments of the levels of receptors for dopamine also did not differ between the two groups.

"So the key difference we found between binge eaters and non-binge eating obese subjects was a fairly subtle elevation of dopamine levels in the caudate in the binge eaters in response to food stimulation," Wang said.

"This dopamine response is in a different part of the brain from what we've observed in studies of drug addiction, which found dopamine spikes in the brain's reward center in response to drug-associated cues. The caudate, in contrast, is believed to be involved in reinforcement of action potentially leading to reward, but not in processing of the reward per se. That means this response effectively primes the brain to seek the reward, which is also observed in drug-addicted subjects," Wang said.

Inasmuch as binge eating is not exclusively found in obese individuals, the scientists believe further studies are warranted to assess the neurobiological factors that may differentiate obese and non-obese binge eaters.

Notes:

This study was funded by the National Institutes of Health through the Intramural Program of the National Institute on Alcoholism and Alcohol Abuse and the General Clinical Research Center of Stony Brook University, using infrastructure supported at Brookhaven Lab by DOE's Office of Science.

Scientific paper: "Enhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder"

Source:
Karen McNulty Walsh
DOE/Brookhaven National Laboratory

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here